1.646.889.1200|info@lifescipublicrelations.com

Reata’s drug, Bardoxolone, shows promising results for chronic kidney disease

/, video/Reata’s drug, Bardoxolone, shows promising results for chronic kidney disease

Reata’s drug, Bardoxolone, shows promising results for chronic kidney disease

Reata is in its ‘final pivotal study’ for its new drug, bardoxolone. In the trials, the drug has showed promising results to reverse kidney damage. Yahoo Finance sits down with the CEO of Reata, Warren Huff, who founded the company in 2002, to discuss the plans to launch the product in the near future.

By | 2019-05-30T11:26:39-04:00 May 22nd, 2019|News, video|Comments Off on Reata’s drug, Bardoxolone, shows promising results for chronic kidney disease

About the Author:

Related Posts

LifeSci Public Relations

LifeSci Public Relations LLC is a corporate communications and public relations firm helping clients engage their corporate audiences and achieve their business objectives via a broad array of traditional, social and digital media tools.